Long Focus Capital Management, LLC Bristol Myers Squibb CO Call Options Transaction History

Long Focus Capital Management, LLC

  • $2.49 Billion
  • Q2 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$72.62 - $79.98 $86.4 Million - $95.2 Million
-1,190,000 Closed
0 $0
Q1 2022

May 13, 2022
SELL
$61.48 - $73.72 $138 Million - $166 Million
-2,246,200 Reduced 65.37%
1,190,000 $86.9 Million
Q4 2021

Feb 14, 2022
BUY
$53.63 - $62.52 $184 Million - $215 Million
3,436,200 New
3,436,200 $214 Million

Others Institutions Holding BMY

# of Institutions
2,428
Shares Held
1.5B
Call Options Held
29.7M
Put Options Held
32.2M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Long Focus Capital Management, LLC Portfolio

Follow Long Focus Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Long Focus Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Long Focus Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email